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DNA-Based Prenatal Diagnosis of Harlequin
Ichthyosis and Characterization of ABCA12 Mutation
Consequences
Masashi Akiyama1,5, Matthias Titeux2,5, Kaori Sakai1, James R. McMillan1, Laure Tonasso2, Patrick Calvas3,
Frederique Jossic4, Alain Hovnanian2,3 and Hiroshi Shimizu1
Until the identification of ABCA12 as the causative gene, prenatal diagnosis (PD) for harlequin ichthyosis (HI)
had been performed by electron microscopic observation of fetal skin biopsy samples. We report the first case
of HI DNA-based PD. Direct sequence analysis of ABCA12 revealed that the deceased proband was a compound
heterozygote for two novel mutations. The maternal nonsense mutation p.Ser1249Term likely leads to
nonsense-mediated messenger RNA decay. The paternal mutation c.7436G4A affects the last codon of exon 50
and was expected to be a splice site mutation. For their third pregnancy, the parents requested PD. Direct
sequence analysis of fetal genomic DNA from amniotic fluid cells at 17 weeks gestation revealed the fetus was a
compound heterozygote for both mutations. The parents requested the pregnancy to be terminated. Analysis of
ABCA12 transcripts of cultured keratinocytes from the abortus showed the presence of six abnormally spliced
products from the allele carrying the splice site mutation. Four of them lead to premature termination codons
whereas the two others produced shortened proteins missing 21 and 31 amino acids from the second ATP-
binding cassette. This report provides evidence for residual ABCA12 expression in HI, and demonstrates the
efficiency of early DNA-based PD of HI.
Journal of Investigative Dermatology (2007) 127, 568–573. doi:10.1038/sj.jid.5700617; published online 2 November 2006
INTRODUCTION
Harlequin ichthyosis (HI) is a severe and usually fatal
congenital ichthyosis with an autosomal recessive inheri-
tance pattern (Williams and Elias, 1987; Akiyama, 2006). The
clinical features include thick, plate-like scales with ectro-
pion, eclabium, and flattened ears. Infants affected with HI
frequently die within the first few weeks of life. Skin
development is altered in utero; hyperkeratosis of the hair
canal occurs in the second trimester and characteristic
ultrastructural abnormalities including abnormal lamellar
granules, are present in the affected fetal epidermis (Dale
et al., 1990; Akiyama et al., 1994, 1998). Before the gene
underlying HI was identified in 2005, prenatal diagnosis (PD)
of the disease relied on ultrastructural examination of fetal
skin biopsy samples at 19–23 weeks estimated gestational age
(EGA) (Blanchet-Bardon et al., 1983; Suzumori and Kanzaki,
1991; Akiyama et al., 1994, 1999).
ABCA12 is a transporter which belongs to the ATP-binding
cassette (ABC) transporter superfamily (Annilo et al., 2002;
Uitto, 2005). In 2005, we identified serious loss of function
mutations in ABCA12 coding an ABC transporter, that leads
to defective lipid transport in epidermal keratinocytes and
results in an HI phenotype (Akiyama et al., 2005). Another
group independently demonstrated that mutations in
ABCA12 underlie HI by linkage analysis (Kelsell et al.,
2005). Thus, HI PD using molecular ABCA12 mutational
analysis has become possible. We report here the first
successful DNA-based PD for HI using fetal genomic DNA
specimens from amniotic fluid cells.
RESULTS
Case history and the clinical features of the proband
The newborn proband was the first child from unrelated,
healthy French parents. He was affected with HI and died
soon after birth. He displayed severe hyperkeratosis with
fissures over his entire body, severe ectropion, and eclabium
(Figure 1a–c). There was no family history of genodermatoses
in the family. The parents had a healthy son, their second
child. For their third pregnancy, the parents requested HI PD.
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ABCA12 mutation analysis
Mutation analysis of the 53 exons including the intron–exon
boundaries of the entire ABCA12 gene revealed that the
proband was a compound heterozygote for two novel
ABCA12 mutations, c.3746C4A and c.7436G4A (sequence
according to Lefe`vre et al. (2003)) (GenBank accession NM
173076) (Figure 1d). c.3746C4A in exon 26 was a novel
nonsense mutation that changed a serine residue at codon
1249 to a stop codon (p.Ser1249Term). This nonsense
mutation p.Ser1249Term in exon 26 likely leads to non-
sense-mediated messenger RNA (mRNA) decay rather than
protein truncation, resulting in ABCA12 deficiency (see
section ABCA12 transcript analysis in cultured keratinocytes
from the fetus). The mutation p.Ser1249Term was also found
in the mother. The other mutation c.7436G4A in exon 50
affects the last amino acid of exon 50 and was expected to be
a splice site mutation. Its potential effects on the splicing
pattern of ABCA12 pre-mRNA were investigated (see section
ABCA12 transcript analysis in cultured keratinocytes from the
fetus). This splice site mutation was found in the father. Thus,
the nonsense mutation p.Ser1249Term was of maternal origin
and the splice site mutation c.7436G4A of paternal origin.
These mutations were not found in 200 normal alleles (50
French and 50 Japanese healthy unrelated individuals) by
sequence analysis, and were unlikely to be polymorphic
variations (data not shown).
DNA-based PD of the fetus
Direct sequencing of PCR products including exon 26 or 50
of ABCA12 from the fetal genomic DNA revealed the
presence of the maternal nonsense mutation p.Ser1249Term
in exon 26 and the paternal splice site mutation c.7436G4A
in exon 50 (Figure 1d). Thus, the fetus harbored both ABCA12
pathogenic mutations and was predicted to be affected. The
pregnancy was terminated at 19 weeks gestation after the
parents’ request. The fetus showed characteristic changes
including thin and fragile skin with petechia, eclabium,
small, thickened and abnormally rimmed ears, rigid and
swollen fingers and toes.
ABCA12 protein expression in the proband’s skin
In the patient, ABCA12 immunostaining in the upper
epidermis was reduced (Figure 1e), when compared with
the intense ABCA12 immunostaining in the upper epidermal
layers, mainly in the granular layers, of normal human skin
(Figure 1f).
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Figure 1. Clinical features of the proband, ABCA12 mutations in the family, and abnormal ABCA12 immunostaining in the patient’s epidermis. (a, b, and c)
Severe hyperkeratosis with fissures covering (a) the proband’s face (b) scalp and back, (c) chest and abdomen. (a) Eclabium and (b) malformed pinna were
apparent. (d) A novel nonsense mutation p.Ser1249Term was found in the proband, the mother, and the fetus (arrows). The novel splice site mutation
c.7436G4A was detected in the proband, the father and the fetus (arrows). The fetus was prenatally diagnosed as affected. (e) In the patient’s upper epidermis,
weak ABCA12 immunostaining (green: arrows) was seen diffusely in the keratinocyte cytoplasm. (f) In normal control human epidermis, intense ABCA12
labeling (green) was noted in the granular layers (arrows). ABCA12, FITC (green); nuclear staining, propidium iodide (red). Bar¼ 10mm.
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Ultrastructure of the skin from the abortus
Autopsy skin samples from the abortus showed abnormal,
vacuolated lamellar granules in the upper intermediate cells
and a large number of lipid droplets in the cytoplasm of
incompletely keratinized keratinocytes.
ABCA12 transcript analysis in cultured keratinocytes from the
fetus
Analysis of reverse transcription-PCR products from cultured
keratinocytes of the fetus HI keratinocyte (HIK) and normal
human keratinocytes (NHKs) on agarose gel electrophoresis
revealed the presence of a single band in NHK PCR products
and three bands in HIK PCR products (data not shown). PCR
products were subsequently cloned and sequenced. A total of
seven different mRNAs generated from the allele carrying the
c.7436G4A mutation were identified (Figure 2a and b).
Transcript p.Arg2479Lys corresponds to the full-length
ABCA12 transcript carrying a lysine residue in place of the
arginine 2479. In addition, six of these transcripts are
generated by splicing from several cryptic splice donor sites
located in exon 50 of ABCA12. Transcript D4 carries a 4 bp
deletion around the mutation (c.7433_7436del) leading to a
frameshift and a PTC 11 amino acids downstream
(p.Arg2479Leufs 11). Transcript D31 displays a 31 bp
deletion (c.7406_7436del) leading to a frameshift and a
PTC 11 downstream (p.Ile2470_Arg24794Leufs11). Tran-
script D43 presents a 43 bp deletion (c.7394_7436del)
leading to a frameshift and a PTC 11 amino acids down-
stream (p.Lys2466_Arg24794Leufs 11). Transcript D50
shows a 50 bp deletion (c.7387_7436del) leading to a
frameshift and a PTC 13 amino acids downstream
(p.Asn2464_Arg24794Trpfs13). Interestingly, transcript
D63 predicts a truncated protein deleted from Leucine 2459
to Arginine 2479 (p.Leu2459_Arg2479del) owing to an in
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Figure 2. Expression analysis of ABCA12 transcripts and protein. (a and b) Sequence alignment of the several transcripts generated by the allele carrying the
paternal splice site mutation c.7436G4A. (a) Wild-type cDNA (blue) and protein sequences of exon 50 of ABCA12. Amino-acid numbering is indicated. (b)
Nucleotide and deduced protein sequences of splice variants of the allele carrying the c.7436G4A mutation (green). Premature stop codons and aberrant
sequences owing to frameshifts are indicated in red. Splice variants include the correctly spliced product (p.Arg2479Lys) and six aberrantly spliced forms leading
to out-of-frame (transcripts D4, D31, D43, and D50) and in-frame (D63 and D93) deletions. (c) Capillary electrophoresis analysis of ABCA12 cDNA amplimers.
Fragments extending over exons 49–53 were amplified by PCR using reverse-transcribed mRNA from primary cultures of HIK and NHKs. Although only one
peak at 422 bp is present in NHK, several peaks are detected in HIK. The peak at 422 bp corresponds to the full-length transcript, arising either from the wild-type
alleles (in NHK) or from the allele carrying the p.Ser1249Term null mutation and from the allele carrying the p.Arg2479Lys mutation (in HIK). The other peaks at
418, 379, 372, 359, and 329 bp, correspond respectively to transcripts D4, D43, D50, D63, and D93. The relative amount of each transcript, evaluated by the
size of the peaks, shows that transcript D63 is predominant. Note that transcript D31 is missing, probably because its synthesis level is below the detection
threshold of this technique. (d) Western blot analysis of ABCA12 protein in NHK and in HIK. A band at 298 kDa (arrow) is present in NHKs extract, however a
slightly lower band (arrowhead, 289 kDa) is present in the HIK extracts. This lower band probably arises from the transcript D63 and to a less extent from the
transcript D93.
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frame deletion of 63 bp (c.7374_7436del), whereas transcript
D93 presents an in frame skipping of the entire exon 50
predicting a truncated protein deleted from Serine 2448 to
Serine 2478 (p.Ser2448_Ser2478del). The cryptic splice sites
used to generate transcripts D4, D31, D50, and D63 were
predicted using the automated splice site analysis software by
Nalla and Rogan (2005).
Capillary electrophoresis analysis of the ABCA12 com-
plementary DNA (cDNA) amplimers showed one amplimer
(422 bp) in NHKs corresponding to the normal sequence of
exon 50, whereas five abnormal species were present in HIK
(Figure 2c). All but one (D31) identified transcripts were
found. The relative amount of transcript, indicated by the
height of the peaks, showed that the D63 transcript is
predominant, whereas the D31 transcript was not detectable.
Interestingly, the height of the peak at 422 bp which arises
from both the p.Arg2479Lys transcript and from the transcript
synthesized from the other ABCA12 allele carrying the
p.Ser1249Term mutation is weak, indicating that the amount
of both transcripts is low. This suggests that the allele carrying
the null mutation is likely to be subjected to nonsense
mediated mRNA decay and that only a small amount of
ABCA12 protein arise from the natural splice site of the pre-
mRNA carrying the c.7436G4A.
ABCA12 protein expression in fetal cultured keratinocytes
Western blot analysis revealed the presence of a band of an
expected molecular weight of 298 kDa in protein extracts
from NHKs, whereas a slightly smaller band of 289 kDa was
seen in HI keratinocyte extracts (Figure 2d). This band
probably corresponds to the proteins synthesized from both
transcript D63 and transcript D93 which are predicted to
encode proteins of calculated molecular weight of 291 and
289 kDa, respectively, and cannot be resolved on the SDS-
PAGE. Smaller bands were seen in both extracts and probably
correspond to degradation products. Western blot analysis
failed to reveal the presence of other shortened proteins in the
extract of HIK. However, the epitope recognized by the
antibody is located at the end of the C-terminus domain of
ABCA12 and thus is not present in the predicted proteins
encoded by transcripts D4, D31, D43, and D50, and by the
product of the allele carrying the p.Ser1249Term mutation.
DISCUSSION
HI is the most severe ichthyotic genodermatosis and has a
very poor prognosis. Therefore, any parents’ request for PD
should be taken very seriously. However, until 2005 the
causative gene had not been identified and previous prenatal
diagnoses were performed using electron microscopic
examination of fetal skin biopsies during the later stages of
pregnancies (Blanchet-Bardon et al., 1983; Suzumori and
Kanzaki, 1991; Akiyama et al., 1994, 1999). HI PD by fetal
skin biopsy was usually performed at 21–22 weeks EGA
(Blanchet-Bardon et al., 1983; Suzumori and Kanzaki, 1991;
Akiyama et al., 1994, 1999). According to these reports, fetal
skin biopsy specimens at that age showed characteristic
abnormalities including a large number of lipid droplets in
the keratinized cells and abnormal or absent lamellar
granules, which were sufficient findings for the PD of the
disorder.
However, PD of HI by fetal skin biopsy is technically
difficult, requires excellent skin biopsy site selection, and is
time-consuming. We need to gain a significant better
understanding of fetal skin development and only a few
experts are able to make this reliable diagnosis. Owing to the
fact that the interfollicular epidermis at 19 weeks EGA or
earlier is not sufficiently developed to exhibit the character-
istic morphologic changes of keratinization (Holbrook and
Odland, 1980), the observations of interfollicular keratino-
cytes are thought to sometime provide insufficient or
unreliable information for PD or prenatal exclusion of HI.
However, at 19 weeks EGA, we were able to see
characteristic ultrastructural HI abnormalities in the kerati-
nized cells in the hair canal or infundibulum of the
developing hair follicle in the case of an affected fetus
(Akiyama et al., 1999). This is because keratinization in the
hair cone and hair canal occurs at around 15 weeks EGA,
approximately 8–9 weeks before the keratinization of inter-
follicular epidermis in human fetal skin development
(Holbrook and Odland, 1978). However, fetal biopsy speci-
mens at 19 weeks EGA may not always provide sufficient
information for PD or exclusion of HI because the inter-
follicular epidermis has not yet keratinized at this stage of
epidermal development (Shimizu et al., 2005).
In 2005, ABCA12 was identified as the underlying gene
causing HI (Akiyama et al., 2005; Kelsell et al., 2005).
Additional HI cases harboring ABCA12 mutations have now
been reported (Akiyama et al., 2006a, b). Owing to these
discoveries, it has now become possible to undertake HI
DNA-based PD by chorionic villus or amniotic fluid sampling
from the earlier stages of pregnancy. These procedures are
technically more reliable and have a reduced burden on the
mothers, as in other severe genetic keratinization disorders
(Tsuji-Abe et al., 2004). We report here a successful PD of HI
using fetal genomic DNA obtained at 17 weeks EGA. It is
anticipated that in the future, even earlier prenatal diagnoses
using completely non-invasive analysis of DNA from fetal
cells in the maternal circulation will be possible (Uitto et al.,
2003), as well as pre-implantation genetic diagnosis for HI
(Shimizu and Suzumori, 1999).
Expression analysis of ABCA12 in cultured keratinoctyes
from the abortus revealed that the allele carrying the
c.7436G4A mutation produced seven different transcripts.
The synthesis of six different truncated or deleted transcripts
from this allele explains the loss of function of this allele. In
particular, transcripts D63 and D93 predict the synthesis of
deleted proteins (deletion of 21 and 31 amino-acid residues,
respectively) with calculated molecular weights of 291 and
289 kDa, which cannot be separated on the SDS-PAGE. Thus,
the protein detected at 289 kDa is likely to arise from both
transcripts, but predominantly from transcript D63, which is
present in higher amount. The two proteins lack part of the
second ATP-binding cassette, which is predicted to drama-
tically affect ABCA12 function. Although, small amounts of a
full-length ABCA12 protein carrying the p.Arg2479Lys
mutation may theoretically be synthesized, they were not
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detected. Thus, loss of ABCA12 function results from the
combination of a null allele, and the synthesis of non-
functional deleted proteins unable to restore a normal
phenotype.
The terminated fetuses in the previous reports of positive
PD of HI showed macroscopic changes consistent with the HI
phenotype at 22 weeks or older EGA (Blanchet-Bardon et al.,
1983; Suzumori and Kanzaki, 1991; Akiyama et al., 1994,
1999). In our previous report, we demonstrated that an
affected fetus already showed a clinically apparent HI
phenotype at 21 weeks EGA (Akiyama et al., 1999).
Characteristic HI changes of HI were seen both macrosco-
pically and ultrastructurally at 19 weeks EGA and the present
case suggests that the HI phenotype has started to emerge in
the affected fetus at the late second trimester of pregnancy.
MATERIALS AND METHODS
Mutation detection
Mutational analysis was performed in the proband and both parents.
Briefly, genomic DNA isolated from peripheral blood was subjected
to PCR amplification, followed by direct automated sequencing
using an ABI PRISM 3100 genetic analyzer (ABI Advanced
Biotechnologies, Columbia, MD). Oligonucleotide primers and
PCR conditions used for amplification of all exons 1–53 of ABCA12
were originally derived from the report by Lefe`vre et al. (2003) and
were partially modified as described previously (Akiyama et al.,
2005). The entire coding region including the exon/intron bound-
aries for both forward and reverse strands from the proband, the
parents and 100 healthy control individuals (50 French and 50
Japanese) were sequenced.
DNA-based prenatal testing
Amniotic fluid cells were obtained under ultrasound guidance at 17
weeks gestation. Fetal DNA was extracted from fresh cells, and
detection of ABCA12 mutations targeting the mutations that were
found in the proband was subsequently performed, as described
above. There were no sonographic findings suggestive of an affected
fetus. No complications arose from the procedure.
Cell culture
Primary human keratinocytes and fibroblasts were obtained from
skin fragments of the abortus and a punch biopsy of a healthy
control. Keratinocytes were cultured on a feeder layer of lethaly
irradiated mouse 3T3-J2 fibroblasts as described previously (Barran-
don and Green, 1987). Fibroblasts were grown in DMEM supple-
mented with 10% heat-inactivated fetal calf serum (Eurobio, Les
Ulis, France).
RNA extraction and reverse transcription-PCR analysis
RNA from cultured keratinocytes and fibroblasts was extracted with
the SV Total RNA Isolation System (Promega, Charbonnie`res,
France), and first-strand cDNA synthesis was carried out using
random hexamer primers and superscript II reverse transcriptase
(Invitrogen, Carlsbad, CA). Next, a segment of the ABCA12 cDNA
was PCR-amplified with primers 50-TCCGTCATCCTCACATCTTCA-
30 (forward) and 50-GAACCTTGGCTGCTGGTATC-30 (reverse) using
Go-Taq polymerase (Promega, Charbonnie`res, France). The cDNA
amplimers were cloned into PGEM-T vector (Promega, Charbon-
nie`res, France) and sequenced using the SP6 primer (50-ATTTAGGT
GACACTATAGAATAC-30) and the T7 primer (50-GTAATACGACT
CACTATAGGGC-30). In parallel, the cDNA amplimers were
analyzed on standard agarose gel and by capillary electrophoresis
on an ABI 310 Genetic Analyzer running the GeneScan software
(Applied Biosystems, Foster City, CA).
Immunohistological and immunoblot analysis of ABCA12
protein expression
Immunodetection of ABCA12 was performed using an affinity
purified anti-ABCA12 serum raised in rabbits using a 14 amino-
acid sequence synthetic peptide (residues 2,567–2,580) derived from
the ABCA12 sequence (NM 173076) as the immunogen (Akiyama
et al., 2005). Immunofluorescent labeling was performed as
described previously (Akiyama et al., 2000). Briefly, 6-mm-thick
sections of fresh patient’s skin were cut using a cryostat. The sections
were incubated in primary antibody solution, anti-ABCA12 anti-
serum diluted 1/10, for 1 hour at 371C. The sections were then
incubated in FITC-conjugated goat anti-rabbit Igs diluted 1:100
(DAKO, Glostrup, Denmark) for 30 minutes at room temperature,
followed by nuclear counterstain by propidium iodide (Sigma
Chemical Co., St Louis, MO). The sections were extensively washed
with phosphate-buffered saline between incubations. The stained
sections were then mounted with a coverslip and observed using a
confocal laser scanning microscope. For Western blot analysis,
proteins were extracted from cultured keratinocytes in the presence
of protease inhibitors (Complete Mini Protease Inhibitor Cocktail,
Roche Diagnostics, Meylan, France), fractionated by SDS-PAGE using
30mg/lane protein on a 4% gel, and transferred to a nitrocellulose
membrane (Hybond-C Extra, Amersham Biosciences, Saclay, France).
Membrane blocking and incubation with antibody (1:5,000) were
carried out in phosphate-buffered saline with 5% skim milk.
Secondary antibody was goat anti-rabbit IgG antibodies conjugated
to horseradish peroxidase (1:5000, Cell Signalling Technology,
Beverley). Signals were revealed with ECLþ chemiluminescence
reagents (GE Healthcare Bio-Sciences Corp., Piscataway, NJ).
Informed consent was obtained from the patients’ parents. This
study was approved by the medical ethical committees at the
Hokkaido University, Sapporo, Japan, Purpan Hospital, Toulouse,
France and Nantes University Hospital, Nantes, France. The study
was conducted according to the Declaration of Helsinki Principles.
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